E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research 


Hemolytic and DNA nicking studies of anti-cancer peptide

Jagatheesh Kaliaperumal, Kowsalya Rangasamy, Parvathavarthini P,Pavankumar Padarthi, Elangovan Namasivayam.

Abstract
Background: In recent years studying of in vitro toxicity encompass their possess significance to proceed any compound to further pharmaceutical procedure. In this we taken peptide which is supposed to be bind with DNA to produce anti-cancer possessions so it requires studying for its genotoxic possessions.

Aims & Objective: To study Hemolytic and DNA nicking of anti-cancer peptide.

Materials and Methods: Simple agarose gel was used to electrophoresis to determine the DNA nicking property and hemolytic assay also performed to ensure the safety of the peptide in biological system.

Results: It was found that peptide is being safe even at elevated concentration 40 ng which cannot be achieved in biological distribution and the hemolytic assay shows the IC50 value 25.24 μg/ml which is also an awfully higher concentration in in vivo terms.

Conclusion: It is concluded the peptide have safe use in biological system.

Key words: Peptide; Electrophoresis; DNA Nicking; Haemolytic Assay


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Jagatheesh Kaliaperumal
Articles by Kowsalya Rangasamy
Articles by Parvathavarthini P
Articles by Pavankumar Padarthi
Articles by Elangovan Namasivayam
on Google
on Google Scholar


REFERENCES
1. Steinstraesser L, Hauk J, Al-Benna S, Langer S, Ring A, Kesting M, et al. Genotoxic and cytotoxic activity of host defense peptides against human soft tissue sarcoma in an in vitro model. Drug Chem Toxicol 2012;35(1):96-103. [DOI via Crossref]   
2. Yu X, Chini CC, He M, Mer G, Chen J. The BRCT domain is a phospho-protein binding domain. Science 2003;302 (5645): 639-42. [DOI via Crossref]   
3. Chaudhary S, Pinkston J, Rabile MM, Van Horn JD. Unusual reactivity in a commercial chromium supplement compared to baseline DNA cleavage with synthetic chromium complexes. Journal of Inorganic Biochemistry 2005;99:787-94. [DOI via Crossref]   
4. Kitts CL, Green CE, Otley RA, Alvarez MA, Unkefer PJ. Type I nitroreductases in soil enterobacteria reduce TNT (2,4,6,-trinitrotoluene) and RDX (hexahydro-1,3,5-trinitro-1,3,5-triazine). Can J Microbiol. 2000;46(3):278-82. [DOI via Crossref]   
5. Andra J, Jakovkin I, Grotzinger J, Hecht O, Krasnosdembskaya AD, Goldmann T, et al. Structure and mode of action of the antimicrobial peptide arenicin. Biochem J 2008;410:113-22. [DOI via Crossref]   
6. Koncar H. In Vitro Genotoxicity Testing. National Institute of Biology. 2011.
7. Yamane K, Tsuruo T. Conserved BRCT regions of TopBP1 and of the tumor suppressor BRCA1 bind strand breaks and termini of DNA. Oncogene 1999;18(37):5194-203. [DOI via Crossref]   
8. U.S. Department of Health and Human Services, Food and Drug Administration, CDER, CBER. Guidance for Industry - Nonclinical Studies for the Safety Evaluation of Pharmaceutical Excipients. 2005. Available from: URL: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm079250.pdf

How to Cite this Article
Pubmed Style

Jagatheesh Kaliaperumal, Kowsalya Rangasamy, Parvathavarthini P,Pavankumar Padarthi, Elangovan Namasivayam. Hemolytic and DNA nicking studies of anti-cancer peptide. Natl J Physiol Pharm Pharmacol. 2014; 4(1): 72-75. doi:10.5455/njppp.2014.4.290820131


Web Style

Jagatheesh Kaliaperumal, Kowsalya Rangasamy, Parvathavarthini P,Pavankumar Padarthi, Elangovan Namasivayam. Hemolytic and DNA nicking studies of anti-cancer peptide. https://www.njppp.com/?mno=43054 [Access: June 01, 2022]. doi:10.5455/njppp.2014.4.290820131


AMA (American Medical Association) Style

Jagatheesh Kaliaperumal, Kowsalya Rangasamy, Parvathavarthini P,Pavankumar Padarthi, Elangovan Namasivayam. Hemolytic and DNA nicking studies of anti-cancer peptide. Natl J Physiol Pharm Pharmacol. 2014; 4(1): 72-75. doi:10.5455/njppp.2014.4.290820131



Vancouver/ICMJE Style

Jagatheesh Kaliaperumal, Kowsalya Rangasamy, Parvathavarthini P,Pavankumar Padarthi, Elangovan Namasivayam. Hemolytic and DNA nicking studies of anti-cancer peptide. Natl J Physiol Pharm Pharmacol. (2014), [cited June 01, 2022]; 4(1): 72-75. doi:10.5455/njppp.2014.4.290820131



Harvard Style

Jagatheesh Kaliaperumal, Kowsalya Rangasamy, Parvathavarthini P,Pavankumar Padarthi, Elangovan Namasivayam (2014) Hemolytic and DNA nicking studies of anti-cancer peptide. Natl J Physiol Pharm Pharmacol, 4 (1), 72-75. doi:10.5455/njppp.2014.4.290820131



Turabian Style

Jagatheesh Kaliaperumal, Kowsalya Rangasamy, Parvathavarthini P,Pavankumar Padarthi, Elangovan Namasivayam. 2014. Hemolytic and DNA nicking studies of anti-cancer peptide. National Journal of Physiology, Pharmacy and Pharmacology, 4 (1), 72-75. doi:10.5455/njppp.2014.4.290820131



Chicago Style

Jagatheesh Kaliaperumal, Kowsalya Rangasamy, Parvathavarthini P,Pavankumar Padarthi, Elangovan Namasivayam. "Hemolytic and DNA nicking studies of anti-cancer peptide." National Journal of Physiology, Pharmacy and Pharmacology 4 (2014), 72-75. doi:10.5455/njppp.2014.4.290820131



MLA (The Modern Language Association) Style

Jagatheesh Kaliaperumal, Kowsalya Rangasamy, Parvathavarthini P,Pavankumar Padarthi, Elangovan Namasivayam. "Hemolytic and DNA nicking studies of anti-cancer peptide." National Journal of Physiology, Pharmacy and Pharmacology 4.1 (2014), 72-75. Print. doi:10.5455/njppp.2014.4.290820131



APA (American Psychological Association) Style

Jagatheesh Kaliaperumal, Kowsalya Rangasamy, Parvathavarthini P,Pavankumar Padarthi, Elangovan Namasivayam (2014) Hemolytic and DNA nicking studies of anti-cancer peptide. National Journal of Physiology, Pharmacy and Pharmacology, 4 (1), 72-75. doi:10.5455/njppp.2014.4.290820131